J
Jay R. Harris
Researcher at Brigham and Women's Hospital
Publications - 282
Citations - 26286
Jay R. Harris is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Breast cancer & Radiation therapy. The author has an hindex of 83, co-authored 282 publications receiving 24560 citations. Previous affiliations of Jay R. Harris include Harvard University & Radiation Therapy Oncology Group.
Papers
More filters
Journal ArticleDOI
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch,E P Winer,A S Coates,R. D. Gelber,M Piccart-Gebhart,B. Thürlimann,H.-J. Senn,Kathy S. Albain,Fabrice Andre,Jonas Bergh,Hervé Bonnefoi,Denisse Bretel-Morales,Harold J. Burstein,Fatima Cardoso,M. Castiglione-Gertsch,Alan S. Coates,Marco Colleoni,Alberto Costa,Giuseppe Curigliano,Nancy E. Davidson,Angelo Di Leo,Bent Ejlertsen,John F. Forbes,Richard D. Gelber,Michael Gnant,Aron Goldhirsch,Pamela J. Goodwin,Paul E. Goss,Jay R. Harris,Daniel F. Hayes,Clifford A. Hudis,James N. Ingle,Jacek Jassem,Zefei Jiang,Per Karlsson,Sibylle Loibl,Monica Morrow,Moïse Namer,C. Kent Osborne,Ann H. Partridge,Frédérique Penault-Llorca,Charles M. Perou,Martine Piccart-Gebhart,Kathleen I. Pritchard,Emiel J. Th. Rutgers,Felix Sedlmayer,Vladimir Semiglazov,Z Shao,Ian E. Smith,Beat Thürlimann,Masakazu Toi,Andrew Tutt,Michael Untch,Giuseppe Viale,Toru Watanabe,Nicholas Wilcken,Eric P. Winer,William C. Wood +57 more
TL;DR: The 13th St Gallen International Breast Cancer Conference (2013) Expert Panel reviewed and endorsed substantial new evidence on aspects of the local and regional therapies for early breast cancer, supporting less extensive surgery to the axilla and shorter durations of radiation therapy.
Journal ArticleDOI
Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).
Benjamin Smith,Benjamin Smith,Douglas W. Arthur,Thomas A. Buchholz,Bruce G. Haffty,Carol A. Hahn,Patricia H. Hardenbergh,Thomas B. Julian,Lawrence B. Marks,Dorin A. Todor,Frank A. Vicini,Timothy J. Whelan,Julia White,Jennifer Y. Wo,Jay R. Harris +14 more
TL;DR: This consensus statement is intended to provide guidance regarding the use ofAPBI outside of a clinical trial and to serve as a framework to promote additional clinical investigations into the optimal role of APBI in the treatment of breast cancer.
Journal ArticleDOI
Breast Cancer Subtype Approximated by Estrogen Receptor, Progesterone Receptor, and HER-2 Is Associated With Local and Distant Recurrence After Breast-Conserving Therapy
Paul L. Nguyen,Alphonse G. Taghian,Matthew S. Katz,Andrzej Niemierko,Rita Abi Raad,Whitney L. Boon,Jennifer R. Bellon,Julia S. Wong,Barbara L. Smith,Jay R. Harris +9 more
TL;DR: Overall, the 5-year local recurrence rate after BCT was low, but varied by subtype as approximated using ER, PR, and HER-2 status, which may be useful in counseling patients about their anticipated outcome after B CT.
Journal ArticleDOI
Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast.
TL;DR: Cosmetic results were lessened when the biopsy procedure included a wide resection of adjacent breast tissue or when theBiopsy scar was obvious, and increasing doses of external beam radiation were associated with greater degrees of retraction and fibrosis of the treated breast.
Journal ArticleDOI
Outcome at 8 Years After Breast-Conserving Surgery and Radiation Therapy for Invasive Breast Cancer: Influence of Margin Status and Systemic Therapy on Local Recurrence
Catherine C. Park,Michihide Mitsumori,Asa J. Nixon,Abram Recht,James L. Connolly,Rebecca Gelman,Barbara Silver,Stella Hetelekidis,Anthony Abner,Jay R. Harris,Stuart J. Schnitt +10 more
TL;DR: Pathologic margin status and the use of adjuvant systemic therapy are the most important factors associated with LR among patients treated with breast-conserving surgery and radiation therapy.